IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Costantino who wrote (878)	5/14/1997 6:55:00 PM
From: Brad C. Dunlap	of 1762

Hi Rick, I'll leave it to you PHD's to translate the exact meaning. About the only word that I recognized was "significant" . I do believe there is a high chance of Idec making a press release after the presentation. I do feel that Coulter is weighting on Idec as their poster presentations are this coming Monday and Tuesday from the ASCO conference. I read their abstract and believe the study is too small and early in not having complete data for high exposure. Nevertheless it is positive. My thoughts are after this conference the spotlight goes back to Idec and gets stronger as we approach the FDA panel meeting. Should be interesting and if you do attend the conference maybe you can feel some of the smithkline people out on CE9.1 in asthma and RA.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next